Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
about
The evolution of poxvirus vaccinesProtective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell ResponsesReview: Capripoxvirus Diseases: Current Status and Opportunities for Control.Developing vaccines against foot-and-mouth disease and some other exotic viral diseases of livestock.An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model.Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus.Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccineExpression of VP7, a Bluetongue virus group specific antigen by viral vectors: analysis of the induced immune responses and evaluation of protective potential in sheepOncolytic bluetongue viruses: promise, progress, and perspectivesExperimental bluetongue virus superinfection in calves previously immunized with bluetongue virus serotype 8.Bluetongue vaccines: the past, present and future.Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.Animal poxvirus vaccines: a comprehensive review.Identification and functional analysis of the GTPV bidirectional promoter region.Opinion of the Scientific Panel on Animal Health an Welfare (AHAW) on the EFSA Selfmandate on bluetongue origin and occurrence
P2860
Q26995905-A22450AB-3DEB-4179-B25C-D1EB954AAD87Q27340815-DB20C6C9-F509-4526-9ED5-F213DC31EF8FQ30252040-30EE3218-E1F7-4CFE-A636-D626DB997278Q34011420-8FC9655A-804A-4CD3-ACB5-1DBCCADBE5AFQ34236757-2C45D3B6-198D-46CB-A7CE-D1E8529A1058Q34238676-BD499D76-9D9C-460B-A622-D9A917EA6632Q34431934-1F1945BC-3752-423D-BBE0-658CA05BE1E3Q34445566-1EA0AEF0-96CA-4538-BD19-A5C31039D6E6Q35084491-54C8796A-A763-4373-B982-68C1A3B4D2F7Q37134049-8AA005AA-2A64-412B-8EDE-9733BBBA9CBBQ37386291-81C0D86B-5092-451E-96DD-72650B976E24Q37643307-783C0232-DA9F-4D41-BCA0-CCC25F47605CQ38068233-04E8F899-8D46-45BE-839D-E412E37E5071Q40490245-29CE9187-79DB-410D-B09D-AC296B37A36DQ47144792-62A46D6D-4374-4219-9FCC-AA322568A1D4
P2860
Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Expression of the major core s ...... ic bluetongue virus challenge.
@en
Expression of the major core s ...... ic bluetongue virus challenge.
@nl
type
label
Expression of the major core s ...... ic bluetongue virus challenge.
@en
Expression of the major core s ...... ic bluetongue virus challenge.
@nl
prefLabel
Expression of the major core s ...... ic bluetongue virus challenge.
@en
Expression of the major core s ...... ic bluetongue virus challenge.
@nl
P2093
P356
P1433
P1476
Expression of the major core s ...... ic bluetongue virus challenge.
@en
P2093
Anderson J
Fleming MJ
Mertens PP
Takamatsu H
Thevasagayam J
Wade-Evans AM
P304
P356
10.1006/VIRO.1996.0306
P407
P577
1996-06-01T00:00:00Z